Showing 1 - 10 of 34,186
Persistent link: https://www.econbiz.de/10003207354
Persistent link: https://www.econbiz.de/10003094071
The dramatic increase of direct-to-consumer advertising (DTCA) of prescription drugs created intensive debates on its effects on patient and doctor behaviors. Combining 1994-2000 DTCA data with the 1995-2000 National Ambulatory Medical Care Surveys, we examine the effect of DTCA on doctor...
Persistent link: https://www.econbiz.de/10012784902
We examine the effect of direct-to-consumer advertising (DTCA) of drug treatment on an important health habit, physical exercise. By learning the existence of a new drug treatment via DTCA, rational consumers may become careless about maintaining healthy lifestyles. Using the National Health...
Persistent link: https://www.econbiz.de/10013214615
Persistent link: https://www.econbiz.de/10005261508
Persistent link: https://www.econbiz.de/10007149038
The year of 1997 witnessed an important change in direct-to-consumer (DTC) advertising of prescription drugs. For the first time, the Food and Drug Administration (FDA) permitted brand-specific DTC ads on TV without a "brief summary" of comprehensive risk information. This led to a three-fold...
Persistent link: https://www.econbiz.de/10014031773
This paper examines the effects of direct-to-consumer advertising (DTCA) of prescription drugs on doctor choice of drug brands. Using antihistamines as an example, we show that DTCA has little effect on the choice of brand despite the massive DTCA expenditure incurred in this class. In contrast,...
Persistent link: https://www.econbiz.de/10014065758
We examine the effect of direct-to-consumer advertising (DTCA) of drug treatment on an important health habit, physical exercise. By learning the existence of a new drug treatment via DTCA, rational consumers may become careless about maintaining healthy lifestyles. Using the National Health...
Persistent link: https://www.econbiz.de/10005720795
Persistent link: https://www.econbiz.de/10006957026